Johnson & Johnson News
The latest news, announcements and press releases from Johnson & Johnson.
Rallybio and J&J collaborate to tackle maternal-foetal blood disorder
The collaboration pact will see Rallybio gaining a $6.6m equity investment from J&J to further a natural history study of FNAIT.
Read the full story »
U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca
(Reuters) - The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its COVID-19 vaccine and has stopped British drugmaker AstraZeneca Plc from using the facility, a senior health official said on Saturday.
Read the full story »
New cancer drugs help Johnson & Johnson edges past profit estimates
Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its cancer drugs Zytiga and Imbruvica helped offset falling sales of arthritis treatment Remicade.
Read the full story »
J&J’s profit beat estimates thanks to new cancer drugs
Gains from its acquisition of Swiss biotech Actelion also helped the bottom line
Read the full story »
New cancer drugs see Johnson & Johnson lift 2017 profit forecast
Second quarter earnings beat forecasts despite slight fall in pharma division
Read the full story »
Johnson & Johnson buys Irish stroke care firm in multimillion euro deal
Sale of Neuravi is largest deal for a venture-backed medtech in Europe since 2009
Read the full story »
J&J discussing breaking up Actelion in acquisition
Negotiations between the two companies had ended earlier this month
Read the full story »
Johnson and Johnson makes takeover approach for Actelion
Acquisition would add to the $246 billion of pharmaceutical deals announced this year
Read the full story »
J&J upbeat on future despite threat to sales of key drug
Arthritis drug Remicade faces challenge from Pfizer biosimilar Inflectra despite ongoing patent lawsuit
Read the full story »
Johnson & Johnson raises 2016 profits forecast
Demand for company’s cancer drug and blood thinner boosts pharmaceutical sales
Read the full story »
J&J's insulin patch finally heading for launch
Johnson & Johnson has finally announced a launch schedule for its One Touch Via insulin patch - some four years after it was first approved in the US.
Read the full story »
Johnson & Johnson to pay $55m in talc-powder trial
Johnson & Johnson has been ordered by a US jury to pay $55m (€47.6m) to a woman who said that using the company's talc-powder products for feminine hygiene caused her to develop ovarian cancer.
Read the full story »
Johnson & Johnson beats earnings expectations
Maker of Band-Aids and Tylenol nudges up its 2016 sales and earnings forecasts
Read the full story »
J&J to cut 3,000 jobs in medical devices division
J&J to cut 3,000 jobs in medical devices division
Read the full story »
Claim This Profile
This is the News section of the company profile page for
Johnson & Johnson on the
Pharmaceutical Services Directory. Companies listed on the directory can update their business
information free of charge. If this is your company and you'd like to claim this profile, please
Contact Us.
Johnson & Johnson company details, activities,
contacts and reviews.
Johnson & Johnson documents, images and videos.
Johnson & Johnson partnership and licensing
opportunities.
Johnson & Johnson latest news, announcements and
press releases.
Johnson & Johnson global factories, offices and
locations.
Johnson & Johnson legal and financial information.
Johnson & Johnson blogs, articles and journal
posts.